Hood River Capital Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-581,886
| Closed | -$18.5M | – | 150 |
|
|
2023
Q2 | $18.5M | Buy |
581,886
+9,010
| +2% | +$286K | 0.55% | 66 |
|
|
2023
Q1 | $14M | Sell |
572,876
-350,762
| -38% | -$8.55M | 0.45% | 69 |
|
|
2022
Q4 | $29.1M | Buy |
923,638
+27,066
| +3% | +$854K | 1.06% | 40 |
|
|
2022
Q3 | $25.3M | Buy |
896,572
+473,322
| +112% | +$13.4M | 0.97% | 39 |
|
|
2022
Q2 | $11.2M | Buy |
+423,250
| New | +$11.2M | 0.44% | 73 |
|